Skip to main content

Month: January 2023

Medigus: Eventer Technologies Signed a Definitive Agreement for Reverse Merger to Become a Public Company

Eventer will merge with a Tel-Aviv Stock Exchange listed company following which Eventer shareholdres will hold 74.99% of the merged company Tel Aviv, Israel, Jan. 09, 2023 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies, and electric vehicle and charging solutions, announced today that its 46.21% owned subsidiary, Eventer Technologies Ltd. (“Eventer”), a software company engaged in the development of platforms enabling producers and venues to create virtual conferences and events including a smart ticketing solution, signed a definitive agreement (“Agreement”) for a planned securities exchange with AI Conversation Systems Ltd. (TASE: AICS) (“AI Conversation Systems”), an Israeli company traded on the...

Continue reading

Consolidated Water Acquires Remaining 39% Interest in PERC Water Corporation for $7.8 Million

GEORGE TOWN, Grand Cayman, Jan. 09, 2023 (GLOBE NEWSWIRE) — Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading developer and operator of advanced water supply and treatment plants, has exercised its option to purchase the remaining 39% equity ownership in its subsidiary, PERC Water Corporation (PERC), for approximately $7.8 million, comprised of $2.44 million in cash and 368,383 shares of common stock valued at approximately $5.36 million. Headquartered in Fountain Valley, California, PERC is a leading water infrastructure company that designs, builds, and operates water and wastewater infrastructure throughout the Western U.S. As a result of the transaction completed on January 4, 2023, Consolidated Water became the 100% owner of PERC. PERC generated revenues of approximately $17.8 million in the first...

Continue reading

Ace Global Business Acquisition Limited Announces Extension of Combination Period and Additional Contribution to Trust Account to Extend Combination Period

New York, Jan. 09, 2023 (GLOBE NEWSWIRE) — Ace Global Business Acquisition Limited (NASDAQ: ACBA, the “Company”), a special purpose acquisition company, announced today that at its annual general meeting of shareholders on January 5, 2023 (the “Meeting”), the Company’s shareholders voted in favor of the proposal to amend its memorandum and articles of association, giving the Company the right to extend the date by which the Company has to complete a business combination (the “Combination Period”) a total of five (5) times, as follows: (i) two (2) times for an additional three (3) months each time from January 8, 2023 to July 8, 2023, followed by (ii) three (3) times for an additional one (1) month each time from July 8, 2023 to October 8, 2023. On January 5, 2023, Ace Global Investment Limited, the Company’s initial public offering...

Continue reading

Navient to announce fourth quarter 2022 results on Jan. 24, host earnings webcast on Jan. 25

WILMINGTON, Del., Jan. 09, 2023 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI), a leader in technology-enabled education finance and business processing solutions, plans to release its 2022 fourth quarter financial results on Navient.com/investors after market close on Tuesday, Jan. 24, 2023. Navient also will host an audio webcast to review results on Wednesday, Jan. 25, 2023, at 8 a.m. Eastern Time. Analysts and investors who wish to ask questions are requested to pre-register at Navient.com/investors anytime ahead of the webcast or at least 15 minutes ahead of start time to receive their personal dial-in access details. Others who wish to join in listen-only mode do not need to pre-register and may simply visit Navient.com/investors to access the webcast. Supplemental financial information and presentation slides used during the...

Continue reading

AmeriCann Reports Record Fiscal Year-End and Quarterly Financial Results

The Company achieved all-time revenue, record net income and substantial EBITDA growth BOSTON, Jan. 09, 2023 (GLOBE NEWSWIRE) — via InvestorWire — AmeriCann Inc. (OTCQB: ACAN) (the “Company”), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, released financial and operational results for its fiscal year and quarter ending September 2022. “Our focus on cost efficiency has produced some of the strongest adjusted operating EBITDA margins in the industry,” said CFO Ben Barton. “We look forward to investing the cash flow we are generating to further expand operations at the Massachusetts Cannabis Center and to produce even better financial results for shareholders. Financial Overview The Company achieved four consecutive quarters of increased operating revenue, culminating...

Continue reading

Nuwellis Reports Preliminary Fourth Quarter and Full Year 2022 Revenue Results

MINNEAPOLIS, Jan. 09, 2023 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced preliminary unaudited results for fourth quarter and full year 2022. Preliminary unaudited revenue for the fourth quarter and full year 2022 is anticipated to be approximately $2.3 million and $8.5 million, respectively, representing an increase of 42% and 8% over the same periods last year. The fourth quarter growth rate reflects benefits from the Company’s commercial team expansion and focused sales strategy, as well as continued market traction in line with the Company’s penetration of market segments beyond heart failure patients. The fourth quarter revenue by segment was led by Pediatrics, followed by Heart Failure...

Continue reading

SeaStar Medical Submits Investigational Device Exemption (IDE) Application to FDA to Study a Novel Therapy to Reduce Hyperinflammation in Adult Acute Kidney Injury Patients

Building upon demonstrated clinical success, the pivotal study will evaluate the Selective Cytopheretic Device in adults with AKI requiring CKRT DENVER, Jan. 09, 2023 (GLOBE NEWSWIRE) — SeaStar Medical (Nasdaq: ICU), a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, has submitted an investigational device exemption (IDE) application to the U.S. Food and Drug Administration (FDA) requesting approval to initiate a pivotal study to evaluate the effectiveness of the Company’s Selective Cytopheretic Device (SCD) in reducing hyperinflammation in adults with acute kidney injury (AKI) requiring continuous kidney replacement therapy (CKRT). The randomized, controlled study is expected to enroll 200 subjects, with a primary endpoint of a composite of 90-day mortality...

Continue reading

Coherus Agrees to Acquire Exclusive U.S. Commercial Rights to Eylea® Biosimilar FYB203 from Klinge Biopharma

Additional Growth Driver Projected to Significantly Increase Mid-to-Long Term Revenue Potential REDWOOD CITY, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Coherus or Coherus BioSciences, Nasdaq: CHRS) announced today that it has executed a binding term sheet with Klinge Biopharma GmbH (Klinge Biopharma) for the exclusive commercialization rights to FYB203, a biosimilar candidate to Eylea® (aflibercept), in the United States. The parties expect to complete the transaction in Q1 2023, and Coherus plans to file a Biologics License Application with the U.S. Food and Drug Administration later this year. Coherus intends to launch the product at Eylea® biosimilar market formation, currently expected to be in 2025, if approved. “This additional ophthalmology product will allow us to broadly target the entire $7 billion...

Continue reading

Autonomous Last Mile Delivery Market Size [2023-2028] worth USD 51.38 Billion | exhibiting a CAGR of 24.4%

The global autonomous last mile delivery was valued USD 8.78 billion in 2020, and is projected to reach USD 51.38 billion valuation by 2028, growing at CAGR of 24.4% by 2028. Pune, Jan. 09, 2023 (GLOBE NEWSWIRE) — According to Fortune Business insights, the global autonomous last mile delivery market to grow USD 51.38 billion by 2028 from its valuation USD 11.12 billion in 2021, at a CAGR of 24.4%. According to our expert researchers, the manufacturing of small mobile delivery robots & drones has seen substantial growth in the last several years on account of the surge in e-commerce business across the world. Industry developments: July 2022- China delivered its drones to resolve its distant rural deliveries and urban pressure demand.Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/autonomous-last-mile-delivery-market-105598Report...

Continue reading

Electric Truck Market Size [2023-2029] worth USD 7,146.4 Million | exhibiting a CAGR of 41.43%

The global Electric Truck was valued USD 505.5 million in 2021, and is projected to reach USD 7,146.4 million valuation by 2029, growing at CAGR of 41.43% from 2023 to 2029. Sky-rocketing fuel prices is main factor for the growth of Electric Truck market in recent years. Pune, Jan. 09, 2023 (GLOBE NEWSWIRE) — According to Fortune Business insights, the global electric trucks market size is expected to grow USD 7,146.4 million by 2029 from its valuation USD 631.3 million in 2022, at a CAGR of 41.43%. According to our analyst, increasing adoption of autonomous driving technology and increasing fuel prices is boosting the electric truck market growth. Key Industry Development: May 2022: 800 Freightliner eCascadia electric trucks will be purchased by Daimler and Sysco; the first lot delivery is planned for the end of the year. By 2026,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.